ALPAT Plant Advanced Technologies SA

EPA · FR · Healthcare · Biotechnology · plantadvanced.com

3.900EUR-8.02%Mkt Cap: 4.83M $P/E: 7.653d ago

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable so…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

$23.37BUSDP/E 14.7

GMAB

Genmab A/S - American Depositary Shares

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap4.83M USD

Enterprise Value9.02M USD

Revenue (TTM)1.49M USD

Gross Profit1.35M USD

Net Income (TTM)618.92K USD

Revenue/Share1.23 EUR

Last Price3.900 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees11

CountryFR

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)7.65

P/E (Forward)-195.00

PEG—

EV/EBITDA37.76

EV/Revenue6.06

P/S3.24

P/B0.45

EPS (TTM)0.51

EPS (Forward)-0.02

52W Range

3.8202% of range8.940

52W High8.940 EUR

52W Low3.820 EUR

Profitability

Gross Margin109.45%

Oper. Margin8.34%

EBITDA Margin16.04%

Profit Margin50.04%

ROE5.79%

ROA3.48%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF2.71M USD

CapEx (TTM)448.28K USD

FCF Margin—

FCF Yield—

Net Debt4.01M USD

Net Debt/EBITDA16.78

Balance Sheet

Debt/Equity0.38

Current Ratio1.30

Quick Ratio0.76

Book Value/Sh8.75 EUR

Cash/Share0.05 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.14M

Float613.47K

Insiders48.10%

Institutions0.00%

Technical

SMA 504.384 (-11.0%)

SMA 2006.452 (-39.6%)

Beta0.82

S&P 52W Chg14.58%

Avg Vol (30d)260

Avg Vol (10d)96

Technical Indicators

RSI (14)19.7

MACD-0.1095

MACD Signal-0.1119

MACD Hist.+0.0024

BB Upper4.436 EUR

BB Middle4.258 EUR

BB Lower4.080 EUR

BB Width8.38%

ATR (14)0.1246 EUR

Vol Ratio (20d)1.93x